Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. [electronic resource]
Producer: 20080228Description: 795-801 p. digitalISSN:- 1555-8576
- Acetylation
- Adult
- Aged
- Antibiotics, Antineoplastic -- pharmacology
- Blotting, Western
- Butyrates -- pharmacology
- Carcinoma, Papillary -- drug therapy
- Cell Proliferation -- drug effects
- Cystadenocarcinoma, Serous -- drug therapy
- Depsipeptides -- pharmacology
- Disease Progression
- Enzyme Inhibitors -- pharmacology
- Female
- Gene Expression Regulation, Enzymologic
- Gene Silencing -- drug effects
- Histone Deacetylase 1
- Histone Deacetylases -- genetics
- Humans
- Hydroxamic Acids -- pharmacology
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- RNA, Small Interfering -- pharmacology
- Transcription, Genetic
- Tumor Cells, Cultured -- drug effects
- Tumor Stem Cell Assay
- Vorinostat
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.